Annual TN EIP Day is Oct. 8, 2020

Annual TN Emerging Infections Program Scientific Presentation Day


Oct. 8, 2020

Note: Due to risks related to COVID-19, this year's EIP Day will be conducted virtually on Zoom. To register, visit the link below and complete the registration.


Prior EIP Day Attendees click here to register.

First-time Attendees click here.


What To Expect:

This is a joint virtual meeting between VUMC, the Tennessee Department of Health, and Vanderbilt University Master of Public Health Program. 

Stay Connected:



How to get CEU credit

Vanderbilt University Medical Center’s Department of Health Policy is approved as a provider of Continuing Education Programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program 137-002-20.

This nursing continuing professional development activity was approved by the Georgia Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

To receive credit for 3.5 contact hours you must:

  • Complete both the RedCAP and Zoom event registration. To receive a RedCAP registration, please email Melinda Eady at
  • Attend the entire Zoom meeting
  • Complete the online evaluation by 11:59 p.m., Friday, October 30, 2020
  • No fewer than 3.5 contact hours may be earned for this meeting.  If you attend fewer than all sessions no contact hours will be earned.

9:00-9:10am           Welcome and Thank You from Dr. William Schaffner and Dr. John Dunn


9:10-9:50am           COVID-19 in Tennessee: Past, Present & Future – Mary-Margaret Fill MD

Tennessee Department of Health

  • Describe the evolution of the COVID-19 pandemic in Tennessee
  • Review the demographic and outcome trends of COVID-19 infections in TN
  • Explain the future direction of the COVID-19 response: challenges and opportunities


9:50-10:20am         TDH Response to COVID-19: Contact Tracing – Jane Yackley, MPH

                  Tennessee Department of Health

  • Describe the overarching strategies of the TDH COVID-19 pandemic response
  • Define contact tracing and its utility in disease transmission mitigation
  • Review the COVID-19 contact tracing efforts in TN


10:20-11:00am       Using the Power of Surveillance to Answer COVID-19 Questions – Lindsay Kim MD, MPH

                  Centers for Disease Control and Prevention

  • Describe the current epidemiology and gaps of COVID-19
  • Describe the implementation of COVID-NET hospitalization surveillance
  • Describe epidemiologic questions that COVID-NET has helped contribute data towards


11:00-11:40am       Household Transmission of SARS-CoV-2 in Nashville, TN – Carlos Grijalva MD, MPH

Vanderbilt University Medical Center

  • Describe the relevance of understanding transmission dynamics
  • Describe the design of the case-ascertained study and main findings
  • Describe the relevance of initial findings, outline next steps and discuss implications for response


11:40-12:05pm       Tennessee Enhanced Mortality Surveillance Data – Rany Octaria MD, MPH and JJ Parker MD

Tennessee Department of Health

  • Describe the national data on baseline characteristics and comorbidities in COVID
  • Describe the data analysis and results of enhanced mortality surveillance and clinical and demographic characteristics among deceased COVID-19 patients in Tennessee
  • Discuss the public health implications of COVID mortality characteristics and comorbidity in Tennessee


12:05-12:25pm       Building the plane while flying it: Diagnostic testing in the COVID-19 pandemic response – Kara Levinson PhD, MPH

                  Tennessee Department of Health

  • Describe the evolution of the COVID-19 diagnostics
  • Define a challenge associated with diagnostic testing during pandemic response
  • Explain the ways in which laboratories contribute to the COVID-19 testing strategy


12:30-1:05pm         Where we are and where we are going: The Landscape of COVID-19 Vaccines –Buddy Creech MD, MPH

Vanderbilt University Medical Center

  • Provide a landscape analysis of COVID-19 vaccines in development
  • Describe preliminary data regarding COVID-19 vaccines
  • Project putative timelines and strategies for eventual deployment of COVID vaccines


1:05pm – 1:10pm    Closing Remarks